Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Pozo

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Plos One|May 17, 2018
Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of secondary-progressive multiple sclerosis: A triple blinded, placebo controlled, randomized phase I/II safety and feasibility studyOscar Fernández, Guillermo Izquierdo, Victoria Fernández, et al.
Theranostics|June 7, 2021
The metabesity factor HMG20A potentiates astrocyte survival and reactive astrogliosis preserving neuronal integrityPetra I Lorenzo, Eugenia Martin Vazquez, Livia López-Noriega, et al.
Nature Communications|April 18, 2018
LRH-1 agonism favours an immune-islet dialogue which protects against diabetes mellitusNadia Cobo-Vuilleumier, Petra I Lorenzo, Noelia García Rodríguez, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Plos One|May 17, 2018
Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of secondary-progressive multiple sclerosis: A triple blinded, placebo controlled, randomized phase I/II safety and feasibility studyOscar Fernández, Guillermo Izquierdo, Victoria Fernández, et al.
Theranostics|June 7, 2021
The metabesity factor HMG20A potentiates astrocyte survival and reactive astrogliosis preserving neuronal integrityPetra I Lorenzo, Eugenia Martin Vazquez, Livia López-Noriega, et al.
Nature Communications|April 18, 2018
LRH-1 agonism favours an immune-islet dialogue which protects against diabetes mellitusNadia Cobo-Vuilleumier, Petra I Lorenzo, Noelia García Rodríguez, et al.
Pageof 7